title: Expansion of a restricted residual host T reg-cell repertoire is dependent on IL-2 following experimental autologous hematopoietic stem transplantation.
abstract: We previously identified a population of residual T(reg)  cells following autologous hematopoietic stem transplantation (HSCT), that rapidly undergoes significant expansion in lymphopenic transplant recipients prior to repopulation by donor de novo derived T(reg)  cells. These CD4(+) Foxp3(+)  T cells provide protection from the development of autoimmune disease. Although ablative conditioning results in excess IL-7 and IL-15, IL-2 is typically not found at high levels following autologous HSCT. We therefore examined the role of these three STAT-5 signaling cytokines in the expansion of residual T(reg)  cells after autologous HSCT. The present study found that the residual T(reg)  cell population included surviving peripheral host Foxp3(+) CD4(+)  T cells whose expansion was critically dependent on IL-2, which could be solely provided by surviving host cells. IL-7 was found to contribute to T(reg)  cell homeostasis, however, not as a growth factor but rather for their persistence. In conjunction with this expansion, TCR spectratype analyses revealed that the residual host T(reg) -cell compartment differed from that present in non-conditioned healthy mice since the residual host Treg cells exhibit a limited TCR diversity. Collectively, these data indicate that the proliferation of T(reg)  and T effector (T(eff) ) cells post-HSCT utilize separate pools of cytokines which has important implications regarding the development of clinical strategies to elicit the desired immune responses in patients post-transplant.
authors.affiliation: Department of Microbiology/Immunology, University of Miami Miller, School of Medicine Miami, FL 33101, USA.
authors.forename: Allison L
authors.initials: AL
authors.lastname: Bayer
authors.forename: Jackeline
authors.initials: J
authors.lastname: Chirinos
authors.forename: Cecilia
authors.initials: C
authors.lastname: Cabello
authors.forename: Jing
authors.initials: J
authors.lastname: Yang
authors.forename: Takaji
authors.initials: T
authors.lastname: Matsutani
authors.forename: Thomas R
authors.initials: TR
authors.lastname: Malek
authors.forename: Robert B
authors.initials: RB
authors.lastname: Levy
mesh_terms: D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D051858:Forkhead Transcription Factors / Q000276:immunology; D018380:Hematopoietic Stem Cell Transplantation; D006413:Hematopoietic System / Q000166:cytology / Q000276:immunology*; D007376:Interleukin-2 / Q000235:genetics / Q000276:immunology*; D015851:Interleukin-7 / Q000276:immunology; D008231:Lymphopenia / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D016176:T-Lymphocyte Subsets / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology* / Q000637:transplantation*; D013950:Thymus Gland / Q000276:immunology
chemical_list: D051858:Forkhead Transcription Factors; C498833:Foxp3 protein, mouse; D007376:Interleukin-2; D015851:Interleukin-7; D011948:Receptors, Antigen, T-Cell